A regulatory miRNA-mRNA network is associated with tissue repair induced by mesenchymal stromal cells in acute kidney injury

Frontiers in Immunology

Volumn 7, Issue JAN, 2017, Pages

  de Almeida, Danilo Candido ^a,b   Bassi, Ênio Jose ^b,c   Azevedo, Hatylas ^b   Anderson, Letícia ^b,d   Origassa, Clarice Silvia Taemi ^a   Cenedeze, Marcos Antônio ^a   de Andrade Oliveira, Vinicius ^b   Felizardo, Raphael José Ferreira ^a   da Silva, Reinaldo Correia ^b   Hiyane, Meire Ioshie ^b   Semedo, Patricia ^a   Reis, Marlene Antônia dos ^e   Moreira Filho, Carlos Alberto ^b   Verjovski Almeida, Sergio ^b,d   Pacheco Silva, Álvaro ^a   Câmara, Niels Olsen Saraiva ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^d INSTITUTO BUTANTAN   (Brazil)

^e FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cellular reprograming; Gene expression; Mesenchymal stromal cells; Microvesicles; MiRNAs

Indexed keywords

CISPLATIN; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY ELECTROPHORESIS; CELL DEATH; CELL PROLIFERATION ASSAY; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE ONTOLOGY; HPRT GENE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY TUBULE CELL; MALE; MEMBRANE MICROPARTICLE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INJURY; TUNEL ASSAY; WESTERN BLOTTING;

EID: 85012077586     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00645     Document Type: Article

References (47)

1. Dimarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol (2013) 4:201. doi:10.3389/fimmu.2013.00201.
2. de Almeida DC, Donizetti-Oliveira C, Barbosa-Costa P, Origassa CS, Câmara NO. In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clin Biochem Rev (2013) 34(3):131-44.
3. Bonventre JV. Microvesicles from mesenchymal stromal cells protect against acute kidney injury. J Am Soc Nephrol (2009) 20(5):927-8. doi:10.1681/ASN.2009030322.
4. Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans (2013) 41(1):283-7. doi:10.1042/BST20120192.
5. Camussi G, Deregibus MC, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens (2010) 19(1):7-12. doi:10.1097/MNH.0b013e328332fb6f.
6. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One (2010) 5(7):e11803. doi:10.1371/journal.pone.0011803.
7. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 200(4):373-83. doi:10.1083/jcb.201211138.
8. Valtieri M, Sorrentino A. The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol (2008) 217(2):296-300. doi:10.1002/jcp.21521.
9. Bruno S, Bussolati B, Grange C, Collino F, di Cantogno LV, Herrera MB, et al. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev (2009) 18(6):867-80. doi:10.1089/scd.2008.0320.
10. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One (2012) 7(3):e33115. doi:10.1371/journal.pone.0033115.
11. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res (2010) 4(3):214-22. doi:10.1016/j.scr.2009.12.003.
12. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) (2014) 92(4):387-97. doi:10.1007/s00109-013-1110-5.
13. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation (2012) 126(22):2601-11. doi:10.1161/CIRCULATIONAHA.112.114173.
14. Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells (2014) 32(1):116-25. doi:10.1002/stem.1504.
15. Zhang B, Yin Y, Lai RC, Tan SS, Choo AB, Lim SK. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev (2014) 23(11):1233-44. doi:10.1089/scd.2013.0479.
16. Raisi A, Azizi S, Delirezh N, Heshmatian B, Farshid AA, Amini K. The mesenchymal stem cell-derived microvesicles enhance sciatic nerve regeneration in rat: a novel approach in peripheral nerve cell therapy. J Trauma Acute Care Surg (2014) 76(4):991-7. doi:10.1097/TA.0000000000000186.
17. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab (2013) 33(11):1711-5. doi:10.1038/jcbfm.2013.152.
18. Le Béchec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, Saumet A, et al. MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model. BMC Bioinformatics (2011) 12:67. doi:10.1186/1471-2105-12-67.
19. Pirooznia M, Nagarajan V, Deng Y. GeneVenn-a web application for comparing gene lists using Venn diagrams. Bioinformation (2007) 1(10):420-2. doi:10.6026/97320630001420.
20. Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res (2012) 40(Web Server issue):W498-504. doi:10.1093/nar/gks494.
21. Delfino KR, Rodriguez-Zas SL. Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS One (2013) 8(3):e58608. doi:10.1371/journal.pone.0058608.
22. Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol Biol (2009) 563:219-39. doi:10.1007/978-1-60761-175-2_12.
23. Thompson KL, Afshari CA, Amin RP, Bertram TA, Car B, Cunningham M, et al. Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ Health Perspect (2004) 112(4):488-94. doi:10.1289/ehp.6676.
24. Huang Q, Dunn RT, Jayadev S, DiSorbo O, Pack FD, Farr SB, et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol Sci (2001) 63(2):196-207. doi:10.1093/toxsci/63.2.196.
25. Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol (2004) 11(3):156-64. doi:10.1097/01.moh.0000131441.10020.87.
26. Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine (2013) 44(1):11-9. doi:10.1007/s12020-012-9839-0.
27. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet (2012) 21(R1):R125-34. doi:10.1093/hmg/dds317.
28. Correa-Costa M, Azevedo H, Amano MT, Gonçalves GM, Hyane MI, Cenedeze MA, et al. Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One (2012) 7(11):e49569. doi:10.1371/journal.pone.0049569.
29. Wang XM, Yao M, Liu SX, Hao J, Liu QJ, Gao F. Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis. Am J Physiol Renal Physiol (2014) 306(2):F205-13. doi:10.1152/ajprenal.90005.2013.
30. Ma SK, Joo SY, Kim CS, Choi JS, Bae EH, Lee J, et al. Increased phosphorylation of PI3K/Akt/mTOR in the obstructed kidney of rats with unilateral ureteral obstruction. Chonnam Med J (2013) 49(3):108-12. doi:10.4068/cmj.2013.49.3.108.
31. Lin SS, Zhu B, Guo ZK, Huang GZ, Wang Z, Chen J, et al. Bone marrow mesenchymal stem cell-derived microvesicles protect rat pheochromocytoma PC12 cells from glutamate-induced injury via a PI3K/Akt dependent pathway. Neurochem Res (2014) 39(5):922-31. doi:10.1007/s11064-014-1288-0.
32. Pandey P, Qin S, Ho J, Zhou J, Kreidberg JA. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease. BMC Syst Biol (2011) 5:56. doi:10.1186/1752-0509-5-56.
33. Dressler GR. The cellular basis of kidney development. Annu Rev Cell Dev Biol (2006) 22:509-29. doi:10.1146/annurev.cellbio.22.010305.104340.
34. Hwang I, Seo EY, Ha H. Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res (2009) 32(12):1653-62. doi:10.1007/s12272-009-2200-3.
35. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun (2012) 3:735. doi:10.1038/ncomms1734.
36. Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res (2012) 347(1):103-16. doi:10.1007/s00441-011-1227-1.
37. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J (2008) 22(12):4126-35. doi:10.1096/fj.08-112326.
38. Lan HY, Chung AC. Transforming growth factor-β and Smads. Contrib Nephrol (2011) 170:75-82. doi:10.1159/000324949.
39. Saal S, Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens (2009) 18(4):317-23. doi:10.1097/MNH.0b013e32832c9da2.
40. Wang G, Kwan BC, Lai FM, Chow KM, Kam-Tao Li P, Szeto CC. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers (2010) 28(2):79-86. doi:10.3233/DMA-2010-0687.
41. Senanayake U, Das S, Vesely P, Alzoughbi W, Fröhlich LF, Chowdhury P, et al. miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms. Carcinogenesis (2012) 33(5):1014-21. doi:10.1093/carcin/bgs126.
42. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, et al. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol (2012) 302(3):F369-79. doi:10.1152/ajprenal.00268.2011.
43. Wang Y, Penfold S, Tang X, Hattori N, Riley P, Harper JW, et al. Deletion of the Cul1 gene in mice causes arrest in early embryogenesis and accumulation of cyclin E. Curr Biol (1999) 9(20):1191-4. doi:10.1016/S0960-9822(00)80024-X.
44. Dealy MJ, Nguyen KV, Lo J, Gstaiger M, Krek W, Elson D, et al. Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E. Nat Genet (1999) 23(2):245-8. doi:10.1038/13886.
45. Lee EJ, Tournier C. The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy. Autophagy (2011) 7(7):689-95. doi:10.4161/auto.7.7.15450.
46. Alers S, Löffler AS, Wesselborg S, Stork B. The incredible ULKs. Cell Commun Signal (2012) 10(1):7. doi:10.1186/1478-811X-10-7.
47. Yan J, Kuroyanagi H, Tomemori T, Okazaki N, Asato K, Matsuda Y, et al. Mouse ULK2, a novel member of the UNC-51-like protein kinases: unique features of functional domains. Oncogene (1999) 18(43):5850-9. doi:10.1038/sj.onc.1202988.